Peichan Zheng
Fujian Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Lipids, and Metabolism, Liver Disease Diagnosis and Treatment, Inflammatory Biomarkers in Disease Prognosis, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → RETRACTED: Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor‐κB‐induced matrix metalloproteinase 2 expression(2014)40 cited
- → CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells(2011)29 cited
- → BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis(2017)27 cited
- → Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study(2021)27 cited
- → CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2(2013)23 cited
- → Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study(2020)22 cited
- → <p>Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study</p>(2020)16 cited
- → Overexpression of CIAPIN1 inhibited pancreatic cancer cell proliferation and was associated with good prognosis in pancreatic cancer(2012)13 cited
- → Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study(2023)12 cited
- → Capn4 is induced by and required for Epstein‐Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP‐1 signaling(2019)10 cited